SEC Form D filing
Dravite Therapeutics, Inc.
Biotech · Series A · Regulation D 506(b) · CA · Filed June 24, 2026
- Offering amount
- $15.0M
- Exemption
- Reg D 506(b)
- Issuer state
- CA
- Filing date
- June 24, 2026
- Signature date
- June 24, 2026
- CIK
- 0002133272
Summary
Auto-generatedBased in California, the issuer's name indicates a focus on therapeutics, placing it in the biotech vertical. The $14,983,333 offering amount in this June 24, 2026 filing under Rule 506(b) anchors a series-a stage.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.